As per the deal, AMRI will be the primary manufacturer and supplier of Rev7, AGC and other polymers present in Rev7 degradable gum products.
The agreement will be executed in accordance with the British Retail Consortium Global Standards for Food Safety and the recognized standards of good manufacturing practice.
AMRI chairman and CEO Thomas E D’Ambra said they look forward to working with Revolymer as it develops and further expands its line of products.
AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates.